Interview with Jean-Philippe Duc, Country Manager, Amgen Czech Republic
Mr. Duc, you first worked in the Czech Republic in 1997, as an Oncology Business Unit manager for Pierre Fabre. The ‘90s in this country have been described to us…
The Senate was established in 1996. 81 senators are elected with a six-year term of office according to the principles of the majority election system. The elections take place every two years, when one third of the Senators are newly elected. Every citizen of the Czech Republic, who is entitled to vote and is at least 40 years old, can be elected to the Senate.
The Senate is conceived as a counterweight to the House of Parliament, as an element establishing conditions for a better quality legislative process and as an element of parliamentary continuity in the event that the House of Parliament is dissolved.
Responsibilities include:
Discusses and approves drafts of bills, which it receives from the House of Parliament
Proposes bills
Expresses its (dis)agreement with international treaties
Expresses its (dis)agreement with declarations of war, with residence of foreign armies in the Czech Republic or with the dispatch of armed forces outside the Czech Republic
Elects the President of the Republic at a joint meeting of both chambers
Expresses its consent to the appointment of Constitutional Court judges
Only the Senate may file an action with the Constitutional Court against the President of the Republic for treason
Submits proposals for the conferral or award of state distinctions
The Senate is not authorised to make any decisions regarding the Czech Republic budget
Mr. Duc, you first worked in the Czech Republic in 1997, as an Oncology Business Unit manager for Pierre Fabre. The ‘90s in this country have been described to us…
Dr. Sommermeyer, you’ve spent approximately two decades working for pharmaceutical companies throughout Europe. From a personal standpoint, why did you decide to leave the industry and found a consultancy? I…
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment, you were tasked with managing the…
Dr. Heger, you were appointed as the Czech Minister of Health in July of 2010. What challenges did you see for the Czech healthcare system, and what has been your…
Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers.…
Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers.…
Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the pharmaceutical business. What do you…
Mr. Krejčí, can you please begin with a broad introduction to Ewopharma, for those of our readers who are unfamiliar with the company? Ewopharma is part of a large group…
Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical Firms), chairing the organization. Dr. Zörner, executive director of…
Mr. Polach, can you please begin with an introduction to CzechBio and explicate the association’s mission on this market? CzechBio is an association of Czech biotech companies that started its…
Mr. Chadim, after Astellas was formed from the merger between Yamanouchi and Fujisawa, it became your job to lead its Czech subsidiary. Tapani Sura, your colleague at Astellas Poland, has…
See our Cookie Privacy Policy Here
